A Study of a Novel Precision Medicine Approach For Obesity

Running, not enrolling · Phase 4 · Has a placebo group

Conditions studied: Obesity

In brief

This study is being done to assess the efficacy of a saliva- based biomarker to predict response to semaglutide for the treatment of obesity.

Key facts

Study ID
NCT06814938
Run by
Mayo Clinic
People needed
135
Starts
2025-02-21
Expected to finish
2028-11-01
Last updated by the study team
2026-07-16

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.